Trial
NCT04406064
Viral Specific T-cells for Treatment of COVID-19
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Children's Hospital Medical Center, Cincinnati
Collaborators
Hoxworth Blood Center
Condition
Viral Infection
Intervention
Viral Specific T-cells (VSTs)
Why stopped
The use of steroids to treat COVID prevents the use of VSTs for these patients. The Principal Investigator does not feel the study had an expectation of enrolling patients as the treatment options for COVID have evolved.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-01-19